The Johns Hopkins University is a private research university in Baltimore, Maryland. Founded in 1876, the university was named for its first benefactor, the American entrepreneur and philanthropist Johns Hopkins. Johns Hopkins is the oldest research university in the United States.

During the past decade, Johns Hopkins University conducted 585 clinical trials. In the 10-year time frame, 585 clinical trials started and 282 clinical trials were completed, i.e. on average, 48.2% percent of trials that started reached the finish line to date. In the past 5 years, 273 clinical trials started and 139 clinical trials were completed. i.e. 50.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins University" #1 sponsor was "Johns Hopkins University" with 233 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 40 trials sponsored, "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 37 trials sponsored, "National Cancer Institute (NCI)" with 36 trials sponsored and "University of California, San Francisco" with 36 trials sponsored. Other sponsors include 749 different institutions and companies that sponsored additional 403 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins University" #1 collaborator was "Johns Hopkins University" with 96 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 54 trials as a collaborator, "National Cancer Institute (NCI)" with 45 trials as a collaborator, "National Institute on Aging (NIA)" with 35 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 25 trials as a collaborator. Other collaborators include 1217 different institutions and companies that were collaborators in the rest 533 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins University" are "HIV Infections" (38 trials), "Prostate Cancer" (27 trials), "Cystic Fibrosis" (23 trials), "Asthma" (17 trials) and "Alzheimer Disease" (16 trials). Many other conditions were trialed in "Johns Hopkins University" in a lesser frequency.

Most popular intervention types in "Johns Hopkins University" are "Drug" (610 trials), "Other" (166 trials), "Behavioral" (98 trials), "Device" (97 trials) and "Biological" (85 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (127 trials), "placebo" (18 trials), "Cyclophosphamide" (16 trials), "laboratory biomarker analysis" (14 trials) and "pharmacological study" (14 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins University" are 1001 trials for "All" genders, 62 trials for "Male" genders and 54 trials for "Female" genders.

Currently, there are 308 active trials in "Johns Hopkins University". 5 are not yet recruiting, 188 are recruiting, 104 are Active, not recruiting, and 11 are Enrolling by invitation. In total, there were 654 completed trials in Johns Hopkins University, 4 suspended trials, and 99 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins University, 194 "Phase 1" clinical trials were conducted, 335 "Phase 2" clinical trials and 203 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 41 trials, and there were also 210 trials that are defined as “Not Applicable".

Johns Hopkins University has several departments that took part in Clinical trials: "Johns Hopkins School of Nursing" - 24 trials, "Johns Hopkins University, The Clinical Trials Unit" - 4 trials, "Department of Neurology; Cognitive Neurology/Neuropsychology" - 3 trials, "Johns Hopkins Univ / Ctr for Immunological Research" - 2 trials